Chronic Hepatitis B Clinical Trials in Hangzhou, Zhejiang
3 recruitingHangzhou, Zhejiang, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment
Chronic Hepatitis B
Fujian Akeylink Biotechnology Co., Ltd.526 enrolled1 locationNCT07090759
Recruiting
Phase 4
Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
Chronic Hepatitis BTenofovir Alafenamide Fumarate
First People's Hospital of Hangzhou50 enrolled1 locationNCT05853718
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
Chronic Hepatitis B Virus (HBV) Infection
Brii Biosciences Limited250 enrolled14 locationsNCT06650852